Trial Profile
A phase 1/2 study assessing the safety and efficacy of apceth-201 in adult steroid-refractory GvHD patients
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 25 Oct 2018
Price :
$35
*
At a glance
- Drugs Apceth-201 (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Apceth Biopharma
- 25 Oct 2018 New trial record